North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmucosal Drug Delivery), By Type (Advanced, Conventional), By Application (Disease Treatment, Research/Academic Purposes), By End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers/Clinics, Others), And Region – Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032

September 2023 | 398 pages | ID: NDCE978919CAEN
Fatpos Global

Abstracts

North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmucosal Drug Delivery), By Type (Advanced, Conventional), By Application (Disease Treatment, Research/Academic Purposes), By End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers/Clinics, Others), And Region – Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts T%li%2032

PRODUCT OVERVIEW

North American Drug Delivery Technologies Market t%li%surpass USD 1080.8 billion by 2032 from USD 423.5 billion in 2021 at a CAGR of 8.9% in the coming years, i.e., 2022-32

Drug delivery systems can be defined as the technologies that transfer drugs throughout or in the body. The delivery mechanism like a pill swallowed by patients or an injection-based vaccine is one such technology. Medicine packaging like a nanoparticle or a micelle, which prevents the drug from degrading and allows it t%li%travel the specific body part, is another term for drug delivery systems. Earlier, doctors tried t%li%administer therapies t%li%the body parts that were directly affected by the sickness. Some medications can be administered locally, which minimizes side effects and drug toxicity while maximizing the effectiveness of a treatment, as opposed t%li%systemically, which has an impact on the entire body.

MARKET HIGHLIGHTS

North American Drug Delivery Technologies Market t%li%surpass USD 1080.8 billion by 2032 from USD 423.5 billion in 2021 at a CAGR of 8.9% in the coming years, i.e., 2022-32. Recently, a number of drug delivery systems have become more noteworthy in the North American market. The most commonly accepted method is controlled release, and it comprises dry powder inhalers, orodispersible tablets (ODT), needle-free injectors, transdermal patches, buccal transmucosal tablets, and aut%li%and pen injectors. Drug distribution through implanted devices is als%li%becoming more popular. These factors are expected t%li%drive the North American Drug Delivery Technologies Market over the estimated period.

North American Drug Delivery Technologies Market Segments:

• By Route of Administration
• Oral Drug Delivery
• Pulmonary Drug Delivery
• Injectable Drug Delivery
• Ocular Drug Delivery
• Nasal Drug Delivery
• Topical Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery
• By Type
• Advanced
• Conventional
• By Application
• Disease Treatment
• Research/Academic Purposes
• By End User
• Hospitals
• Home Care Settings
• Ambulatory Surgical Centers/Clinics
• Others

MARKET DYNAMICS

Growth Drivers

Growing Prevalence of Several Chronic Diseases and Innovations in the Drug Delivery Systems

Progressing Biologics Domain and Growing Competition due t%li%the Production of Branded and Generic Drugs

Restraint

Strict Regulations by the FDA for Approval of Drugs and Medical Devices

Key Players

• Johnson & Johnson Inc.
• Medtronic PLC
• 3M Company
• Pfizer Inc
• Becton, Dickinson and Company
• Merck & Co. Inc.
• Boston Scientific Corporation
• Cipla Inc.
• Gerresheimer AG
• West Pharmaceutical Services Inc.
• Other Prominent Players

(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons t%li%Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight int%li%the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
• 3-month post-sales analyst support.

Contents

1 EXECUTIVE SUMMARY

1.1. Regional Market Share
1.2. Business Trends
1.3. North American Drug Delivery Technologies Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot

2 RESEARCH METHODOLOGY

2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
  2.5.1. Paid Sources
  2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation

3 MARKET CHARACTERISTICS

3.1. Market Definition
3.2. North American Drug Delivery Technologies Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4 NORTH AMERICAN DRUG DELIVERY TECHNOLOGIES MARKET – INDUSTRY INSIGHTS

4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5 MACROECONOMIC INDICATORS


6 RECENT DEVELOPMENTS


7 MARKET DYNAMICS

7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends

8 RISK ANALYSIS


9 MARKET ANALYSIS

9.1. Porters Five Forces
9.2. PEST Analysis
  9.2.1. Political
  9.2.2. Economic
  9.2.3. Social
  9.2.4. Technological

10 NORTH AMERICAN DRUG DELIVERY TECHNOLOGIES MARKET

10.1. Overview
10.2. Historical Analysis (2016-2020)
  10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11 NORTH AMERICAN DRUG DELIVERY TECHNOLOGIES MARKET SIZE & FORECAST 2022A-2032F

11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
  11.3.1. By Route of Administration
    11.3.1.1. Oral Drug Delivery
      11.3.1.1.1. By Value (USD Million) 2022-2032F
      11.3.1.1.2. Market Share (%) 2022-2032F
      11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
    11.3.1.2. Pulmonary Drug Delivery
      11.3.1.2.1. By Value (USD Million) 2022-2032F
      11.3.1.2.2. Market Share (%) 2022-2032F
      11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
    11.3.1.3. Injectable Drug Delivery
      11.3.1.3.1. By Value (USD Million) 2022-2032F
      11.3.1.3.2. Market Share (%) 2022-2032F
      11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
    11.3.1.4. Ocular Drug Delivery
      11.3.1.4.1. By Value (USD Million) 2022-2032F
      11.3.1.4.2. Market Share (%) 2022-2032F
      11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
    11.3.1.5. Nasal Drug Delivery
      11.3.1.5.1. By Value (USD Million) 2022-2032F
      11.3.1.5.2. Market Share (%) 2022-2032F
      11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
    11.3.1.6. Topical Drug Delivery
      11.3.1.6.1. By Value (USD Million) 2022-2032F
      11.3.1.6.2. Market Share (%) 2022-2032F
      11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
    11.3.1.7. Implantable Drug Delivery
      11.3.1.7.1. By Value (USD Million) 2022-2032F
      11.3.1.7.2. Market Share (%) 2022-2032F
      11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
    11.3.1.8. Transmucosal Drug Delivery
      11.3.1.8.1. By Value (USD Million) 2022-2032F
      11.3.1.8.2. Market Share (%) 2022-2032F
      11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F
  11.3.2. By Type
    11.3.2.1. Advanced
      11.3.2.1.1. By Value (USD Million) 2022-2032F
      11.3.2.1.2. Market Share (%) 2022-2032F
      11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
    11.3.2.2. Conventional
      11.3.2.2.1. By Value (USD Million) 2022-2032F
      11.3.2.2.2. Market Share (%) 2022-2032F
      11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
  11.3.3. By Application
    11.3.3.1. Disease Treatment
      11.3.3.1.1. By Value (USD Million) 2022-2032F
      11.3.3.1.2. Market Share (%) 2022-2032F
      11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
    11.3.3.2. Research/Academic Purposes
      11.3.3.2.1. By Value (USD Million) 2022-2032F
      11.3.3.2.2. Market Share (%) 2022-2032F
      11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
  11.3.4. By End User
    11.3.4.1. Hospitals
      11.3.4.1.1. By Value (USD Million) 2022-2032F
      11.3.4.1.2. Market Share (%) 2022-2032F
      11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
    11.3.4.2. Home Care Settings
      11.3.4.2.1. By Value (USD Million) 2022-2032F
      11.3.4.2.2. Market Share (%) 2022-2032F
      11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
    11.3.4.3. Ambulatory Surgical Centers/Clinics
      11.3.4.3.1. By Value (USD Million) 2022-2032F
      11.3.4.3.2. Market Share (%) 2022-2032F
      11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
    11.3.4.4. Others
      11.3.4.4.1. By Value (USD Million) 2022-2032F
      11.3.4.4.2. Market Share (%) 2022-2032F
      11.3.4.4.3. Y-o-Y Growth (%) 2022-2032F

12 UNITED STATES DRUG DELIVERY TECHNOLOGIES MARKET SIZE & FORECAST 2022A-2032F

12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
  12.3.1. By Route of Administration
  12.3.2. By Type
  12.3.3. By Application
  12.3.4. By End User

13 CANADA DRUG DELIVERY TECHNOLOGIES MARKET SIZE & FORECAST 2022A-2032F

13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
  13.3.1. By Route of Administration
  13.3.2. By Type
  13.3.3. By Application
  13.3.4. By End User

14 COMPETITIVE LANDSCAPE

14.1. Company market share, 2021
14.2. Key player overview
14.3. Key stakeholders

15 COMPANY PROFILES

15.1. Johnson & Johnson Inc.
  15.1.1. Company Overview
  15.1.2. Financial Overview
  15.1.3. Key Product; Analysis
  15.1.4. Company Assessment
    18.1.4.1 Product Portfolio
    18.1.4.2 Key Clients
    18.1.4.3 Market Share
    18.1.4.4 Recent News & Development (Last 3 Yrs.)
    18.1.4.5 Executive Team
15.2. Medtronic PLC
15.3. 3M Company
15.4. Pfizer Inc
15.5. Becton, Dickinson and Company
15.6. Merck & Co. Inc.
15.7. Boston Scientific Corporation
15.8. Cipla Inc.
15.9. Gerresheimer AG
15.10. West Pharmaceutical Services Inc.
15.11. Other Prominent Players

16 APPENDIX


17 CONSULTANT RECOMMENDATION